We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$243B
AUM Growth
+$27.2B
Cap. Flow
+$7.37B
Cap. Flow %
3.03%
Top 10 Hldgs %
14.51%
Holding
8,546
New
751
Increased
3,655
Reduced
3,100
Closed
633

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.15%
2 Financials 7.85%
3 Technology 7.27%
4 Healthcare 5.66%
5 Industrials 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FINZ
7426
DELISTED
ProShares UltraPro Short Financial Select Sector
FINZ
$4K ﹤0.01%
515
+12
+2% +$112
PTX
7427
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$4K ﹤0.01%
1,638
-999
-38% -$2.76K
CELP
7428
DELISTED
Cypress Environmental Partners, L.P.
CELP
$4K ﹤0.01%
711
+384
+117% +$2.65K
AEF
7429
abrdn Emerging Markets Equity Income Fund
AEF
$386M
$3K ﹤0.01%
300
-431
-59% -$3.71K
ARMP icon
7430
Armata Pharmaceuticals
ARMP
$151M
$3K ﹤0.01%
230
-1,081
-82% -$16K
ATXS
7431
DELISTED
Astria Therapeutics
ATXS
$3K ﹤0.01%
36
-13
-27% -$1.53K
AYTU icon
7432
AYTU BioPharma
AYTU
$21.1M
0
BBGI icon
7433
Beasley Broadcasting Group
BBGI
$31.3M
$3K ﹤0.01%
12
-26
-68% -$5.9K
CARM
7434
DELISTED
Carisma Therapeutics
CARM
$3K ﹤0.01%
203
+103
+103% +$1.92K
CKPT
7435
DELISTED
Checkpoint Therapeutics
CKPT
$3K ﹤0.01%
84
+3
+4% +$157
BGMS
7436
Bio Green Med Solution Inc
BGMS
$6.56M
0
DNLI icon
7437
Denali Therapeutics
DNLI
$3.21B
$3K ﹤0.01%
+200
New +$3.59K
DOGZ icon
7438
Dogness International Corp
DOGZ
$15.7M
$3K ﹤0.01%
+21
New +$2.45K
FPAY
7439
DELISTED
FlexShopper
FPAY
$3K ﹤0.01%
+664
New +$2.71K
GAA icon
7440
Cambria Global Asset Allocation ETF
GAA
$76.6M
$3K ﹤0.01%
+106
New +$2.88K
GIGB icon
7441
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$969M
$3K ﹤0.01%
+50
New +$2.5K
GLBS icon
7442
Globus Maritime Ltd
GLBS
$82M
$3K ﹤0.01%
2
+1
+100% +$1.08K
GNSS icon
7443
Genasys
GNSS
$68.3M
$3K ﹤0.01%
1,388
-1,679
-55% -$3.6K
HACK icon
7444
PUT
Amplify Cybersecurity ETF
HACK
$3.08B
$3K ﹤0.01%
100
HFBL icon
7445
Home Federal Bancorp
HFBL
$73.6M
$3K ﹤0.01%
+200
New +$2.72K
HYXF icon
7446
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$192M
$3K ﹤0.01%
66
-34
-34% -$1.75K
ISHP icon
7447
First Trust Exchange-Traded Fund VI First Trust S-Network E-Commerce ETF
ISHP
$5.17M
$3K ﹤0.01%
+125
New +$2.54K
JHSC icon
7448
John Hancock Multifactor Small Cap ETF
JHSC
$704M
$3K ﹤0.01%
+100
New +$2.56K
KNDI
7449
Kandi Technologies Group
KNDI
$58.6M
$3K ﹤0.01%
400
LTBR icon
7450
Lightbridge
LTBR
$228M
$3K ﹤0.01%
227
-95
-30% -$1.21K

Similar funds

UBS Group's Q4 2017 Portfolio in Review

As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group deployed $7.37B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 54% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.

  • UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
  • UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
  • UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
  • UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
  • UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
  • UBS Group opened 751 new positions and closed 633 in Q4 2017.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.